Violation Tracker Summary for Primary Offense Type

Offense Type: 
off-label or unapproved promotion of medical products
Penalty Total since 2000: 
Number of Penalty Records: 
The totals here are adjusted to account for the fact that each parent's entries may include both agency records and settlement announcements for the same case; or else a penalty covering multiple locations may be listed in the individual records for each of the facilities. They are also adjusted to reflect cases in which federal and state or local agencies cooperated and issued separate announcements of the outcome. Duplicate or overlapping penalty amounts are marked with an asterisk in the individual records list below.

Top 10 Parent CompaniesTotal Penalty $Number of Records
Purdue Pharma$10,019,500,0002
Johnson & Johnson$8,136,000,00011
Cardinal Health$6,489,000,0001
Eli Lilly$1,608,100,0009

Individual Penalty Records:

Click on the company or penalty amount for more information on each case. Click on the parent name to reach the summary page for that parent company.
Download results as CSV or XML (maximum 10,000; for access to larger downloads contact Phil Mattera)
Company Parent Parent Major Industry Year Agencysort icon Penalty Amount
Serono Inc. Merck KGaA (EMD) pharmaceuticals 2005 MULTI-AG (*) $262,000,000
Shire Pharmaceuticals LLC Takeda Pharmaceutical pharmaceuticals 2014 MULTI-AG (*) $20,786,034
UCB Inc. UCB pharmaceuticals 2011 MULTI-AG (*) $9,893,322
Warner-Lambert Pfizer pharmaceuticals 2004 MULTI-AG (*) $190,000,000
Wyeth Pharmaceuticals, Inc. Pfizer pharmaceuticals 2013 MULTI-AG (*) $257,400,000
McKinsey & Company McKinsey business services 2021 MULTI-AG $573,000,000
Indivior plc Indivior Inc. pharmaceuticals 2021 MULTI-AG $300,000,000
Purdue Pharma Purdue Pharma pharmaceuticals 2021 MULTI-AG $10,000,000,000
Johnson & Johnson Johnson & Johnson pharmaceuticals 2021 MULTI-AG $5,000,000,000
Cardinal Health Inc. Cardinal Health wholesalers 2021 MULTI-AG $6,489,000,000
AmerisourceBergen Corporation AmerisourceBergen wholesalers 2021 MULTI-AG $6,510,000,000
McKesson Corporation McKesson wholesalers 2021 MULTI-AG $8,001,000,000
Endo Health Solutions Endo International pharmaceuticals 2021 NY-AG $50,000,000
Insys Insys Therapeutics pharmaceuticals 2015 OR-AG $1,100,000
Stryker Biotech, LLC Stryker medical equipment and supplies 2011 OR-AG $167,000
Johnson & Johnson Johnson & Johnson pharmaceuticals 2012 TX-AG $158,000,000
Novartis Pharmaceuticals Novartis pharmaceuticals 2012 TX-AG $6,638,250
Inspire Pharmaceuticals Inc. Merck pharmaceuticals 2015 USAO $5,900,000
SB Medical Inc. and TC Medical Group   2015 USAO $75,000,000
Janssen Pharmaceuticals, Inc. Johnson & Johnson pharmaceuticals 2013 USAO $410,000,000
GeneScience Pharmaceutical Company   2010 USAO $7,500,000
Specialty Distribution Services Inc. Cigna healthcare services 2007 USAO $10,500,000
Jazz Pharmaceuticals Inc. Jazz Pharmaceuticals pharmaceuticals 2007 USAO $20,000,000
Schering-Plough Corporation Merck pharmaceuticals 2006 USAO $435,000,000
Abbott Laboratories AbbVie pharmaceuticals 2018 USAO $25,000,000
Carefusion Corporation Becton Dickinson medical equipment and supplies 2019 USAO $3,300,000
Avalign Technologies Inc.   2019 USAO $9,500,000
Download results as CSV or XML (maximum 10,000; for access to larger downloads contact Phil Mattera)
(*): Some penalties are partial or complete duplicates of other penalty records, either because a DOJ settlement duplicates an agency record or because EPA listed the full penalty for a company for each of the company's relevant facilities. Penalty amounts marked with an asterisk have been identified by Good Jobs First as duplicating other penalty amounts.